164 related articles for article (PubMed ID: 23849097)
1. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism.
Nieto JA; Solano R; Trapero Iglesias N; Ruiz-Giménez N; Fernández-Capitán C; Valero B; Tiberio G; Bura-Riviere A; Monreal M;
Thromb Res; 2013 Aug; 132(2):175-9. PubMed ID: 23849097
[TBL] [Abstract][Full Text] [Related]
2. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry.
Ruíz-Giménez N; Suárez C; González R; Nieto JA; Todolí JA; Samperiz AL; Monreal M;
Thromb Haemost; 2008 Jul; 100(1):26-31. PubMed ID: 18612534
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE registry.
Nuñez MJ; Villalba JC; Cebrián E; Visoná A; Lopez-Jimenez L; Núñez M; Szwebel TA; Luque JM; Jaras MJ; Monreal M;
Thromb Res; 2012 Aug; 130(2):173-7. PubMed ID: 22374336
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
[TBL] [Abstract][Full Text] [Related]
5. Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis.
Muñoz-Torrero JF; Bounameaux H; Pedrajas JM; Lorenzo A; Rubio S; Kearon C; Hernández L; Monreal M;
J Vasc Surg; 2011 Dec; 54(6 Suppl):26S-32S. PubMed ID: 21908150
[TBL] [Abstract][Full Text] [Related]
6. Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
Farge D; Trujillo-Santos J; Debourdeau P; Bura-Riviere A; Rodriguez-Beltrán EM; Nieto JA; Peris ML; Zeltser D; Mazzolai L; Hij A; Monreal M;
Medicine (Baltimore); 2015 Aug; 94(32):e1235. PubMed ID: 26266353
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry.
Nieto JA; Camara T; Gonzalez-Higueras E; Ruiz-Gimenez N; Guijarro R; Marchena PJ; Monreal M;
Thromb Haemost; 2008 Nov; 100(5):789-96. PubMed ID: 18989522
[TBL] [Abstract][Full Text] [Related]
8. Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study.
Riva N; Bellesini M; Di Minno MN; Mumoli N; Pomero F; Franchini M; Fantoni C; Lupoli R; Brondi B; Borretta V; Bonfanti C; Ageno W; Dentali F
Thromb Haemost; 2014 Sep; 112(3):511-21. PubMed ID: 24899092
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in neurosurgical patients who develop venous thromboembolism: a review of the RIETE registry.
Cote LP; Greenberg S; Caprini JA; Stone J; Arcelus JI; López-Jiménez L; Rosa V; Schellong S; Monreal M;
Clin Appl Thromb Hemost; 2014 Nov; 20(8):772-8. PubMed ID: 24798686
[TBL] [Abstract][Full Text] [Related]
10. Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs.
Lozano F; Trujillo-Santos J; Barrón M; Gallego P; Babalis D; Santos M; Falgá C; Monreal M;
J Vasc Surg; 2014 May; 59(5):1362-7.e1. PubMed ID: 24439322
[TBL] [Abstract][Full Text] [Related]
11. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry.
Laporte S; Mismetti P; Décousus H; Uresandi F; Otero R; Lobo JL; Monreal M;
Circulation; 2008 Apr; 117(13):1711-6. PubMed ID: 18347212
[TBL] [Abstract][Full Text] [Related]
12. Fondaparinux in the initial and long-term treatment of venous thromboembolism.
Pesavento R; Amitrano M; Trujillo-Santos J; Di Micco P; Mangiacapra S; López-Jiménez L; Falgá C; García-Bragado F; Piovella C; Prandoni P; Monreal M;
Thromb Res; 2015 Feb; 135(2):311-7. PubMed ID: 25543161
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
14. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in cancer patients with acute venous thromboembolism.
Martín-Martos F; Trujillo-Santos J; Barrón M; Vela J; Javier Marchena P; Braester A; Hij A; Hernández-Blasco L; Verhamme P; Manuel M;
Thromb Res; 2015 Feb; 135 Suppl 1():S12-5. PubMed ID: 25903526
[TBL] [Abstract][Full Text] [Related]
16. Validation of two clinical prognostic models in patients with acute symptomatic pulmonary embolism.
Ferrer M; Morillo R; Elías T; Jara L; García L; Nieto R; Sandoval E; Uresandi F; Otero R; Jiménez D
Arch Bronconeumol; 2013 Oct; 49(10):427-31. PubMed ID: 23664248
[TBL] [Abstract][Full Text] [Related]
17. Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry.
Bruscas MJ; Nieto JA; Perez-Pinar M; López-Jiménez L; Fernández-Capitán C; López-Chuliá F; Orue-Lecue MT;
Ann Hematol; 2007 Jul; 86(7):519-26. PubMed ID: 17437112
[TBL] [Abstract][Full Text] [Related]
18. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism in nonagenarians. Findings from the RIETE Registry.
Vasco B; Villalba JC; Lopez-Jimenez L; Falga C; Montes J; Trujillo-Santos J; Monreal M;
Thromb Haemost; 2009 Jun; 101(6):1112-8. PubMed ID: 19492156
[TBL] [Abstract][Full Text] [Related]
20. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
